Gainers
- Acorda Therapeutics ACOR stock moved upwards by 56.69% to $5.97 during Friday's pre-market session. The market value of their outstanding shares is at $66.4 million.
- NRX Pharmaceuticals NRXP shares rose 48.81% to $24.48. The market value of their outstanding shares is at $1.1 billion.
- Medigus MDGS shares increased by 23.17% to $1.86. The market value of their outstanding shares is at $44.2 million.
- Cyclerion Therapeutics CYCN shares rose 18.05% to $4.25. The market value of their outstanding shares is at $171.7 million.
- Xenetic Biosciences XBIO stock rose 15.64% to $2.15. The company's market cap stands at $18.8 million.
- NeuroMetrix NURO shares moved upwards by 8.97% to $26.95. The market value of their outstanding shares is at $133.2 million. As per the news, the Q2 earnings report came out yesterday.
Losers
- AzurRx BioPharma AZRX stock decreased by 23.94% to $0.54 during Friday's pre-market session. The company's market cap stands at $42.3 million.
- Adverum Biotechnologies ADVM shares declined by 19.61% to $2.46. The market value of their outstanding shares is at $240.9 million.
- Applied DNA Sciences APDN stock decreased by 10.5% to $5.8. The company's market cap stands at $43.4 million.
- Chembio Diagnostics CEMI shares decreased by 8.36% to $3.95. The company's market cap stands at $79.9 million.
- Sonnet BioTherapeutics SONN shares fell 6.96% to $1.07. The company's market cap stands at $22.8 million.
- ChromaDex CDXC stock fell 6.63% to $9.72. The company's market cap stands at $660.3 million.
© 2025 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Posted In:
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in